🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Niannian Ji

The University of Texas at San Antonio Health Science Center

ORCID: 0000-0001-5852-6484

Also affiliated with Icahn School of Medicine at Mount Sinai

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer”.

Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03236-y
N/A
0.330DataRank · unranked
8 citations

Meijun Long, Andreu Garcia‐Vilanova, Russell Ault, Juan I. Moliva, Kizil A. Yusoof +6 more

γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0285
N/A
0DataRank · unranked
19 citations

Neelam Mukherjee, Zhen‐Ju Shu, Ryan M. Reyes, Joshua J. Meeks, David J. McConkey +4 more

Glucan particles as a novel adjuvant for the induction of experimental autoimmune encephalomyelitis

Cellular Immunology(2021)10.1016/j.cellimm.2021.104383
N/A
0DataRank · unranked
6 citations

Niannian Ji, Robert L. Reddick, Gary R. Ostroff, Thomas G. Forsthuber, Carol Chase Huizar

KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer

Cancer Medicine(2022)10.1002/cam4.5579
N/A
0DataRank · unranked
16 citations

Niannian Ji, Xi Tan, Chun‐Liang Chen, Onika D.V. Noel, Maria Rodriguez‐Padron +5 more

Data from γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer

(2023)10.1158/2326-6066.c.6550607
N/A
0DataRank · unranked
0 citations

Neelam Mukherjee, Zhen‐Ju Shu, Ryan M. Reyes, Joshua J. Meeks, David J. McConkey +4 more

Perioperative Immune Checkpoint Blockade for Muscle-Invasive and Metastatic Bladder Cancer

Journal of Cancer Immunology(2024)10.33696/cancerimmunol.6.081
N/A
0DataRank · unranked
4 citations

Karen Wheeler, Shaun Trecarten, Zaineb Hassouneh, Niannian Ji, Yi‐Fen Lee +3 more

CD56 on intratumoral NK cells: orchestrating NK cell-mediated anti-tumor effects in bladder cancer

Neoplasia(2025)10.1016/j.neo.2025.101187
N/A
0DataRank · unranked
2 citations

Onika D.V. Noel, Niannian Ji, M. Kim, Natalia Bowman, Robert S. Svatek +3 more

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002051
N/A
0DataRank · unranked
22 citations

Yilun Deng, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler +11 more

A Double‐Humanized Murine Model in Bladder Cancer: A Novel Preclinical Model for Cancer Immunology Research

Cancer Medicine(2025)10.1002/cam4.71150
N/A
0DataRank · unranked
1 citations

Zaineb Hassouneh, Shaun Trecarten, Zhen-Ju Shu, Jaime Furman, Tyler J. Curiel +3 more